Medical Research News

RSS

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Study demonstrates causal relationship between onset of Creutzfeldt-Jakob disease and general surgery

A new study spearheaded by Spanish scientists demonstrates a causal relationship between the onset of Creutzfeldt-Jakob disease (CJD), caused by a protein called a prion, and general surgery. CJD manifests itself in hereditary acquired; and sporadic forms, or for unknown reasons, which accounts for the majority of cases.

8 Jul 2010

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce that it has entered into a long-term lease on a 9,500 square foot facility in Denver, Colorado, that will become its corporate offices, as well as serving as a research facility for developing, testing, and producing medical cannabis for patients in compliance with the new Colorado laws regulating medical marijuana in the state.

8 Jul 2010

Study: 30-minute massage improves psychological, physiological state of patients with tension headache

Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage.

8 Jul 2010

Alzheimer's disease patients may have decreased ability to experience emotions

Watching a loved one struggle with Alzheimer's disease can be a painful process, but for the patient, the experience may be a muted one.

8 Jul 2010

Dietary protein intake may reduce bone density in overweight, postmenopausal women: Research

Overweight and moderately obese postmenopausal women using diets based on higher protein intake also need to be aware of potential bone loss, according to new research from Purdue University.

8 Jul 2010

Study of latest in clinical data technology applied to Phase II clinical trial in South Africa

Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.

8 Jul 2010

Patients with hyperglycaemia during acute illness have increased risk of developing diabetes: Researchers

Hyperglycemia during critical illness may be used as a warning of future diabetes. Researchers writing in BioMed Central's open access journal Critical Care have found a significant association between acute illness complicated with hyperglycaemia and the future development of type II diabetes or glucose intolerance.

8 Jul 2010

UTHealth Biotechnology Commercialization Center leases over three-quarters of available space

The University of Texas Health Science Center at Houston (UTHealth) announced that its Biotechnology Commercialization Center (BCC) has leased more than three-quarters of its available space to eight Texas-based startups in less than a year. The center's focus is to assist biotech entrepreneurs and small companies with the translation of discoveries into innovative health solutions.

8 Jul 2010

MicroRNA-212 plays key role in determining vulnerability to cocaine addiction: Study

Scientists from The Scripps Research Institute have found that a particular type of genetic material plays a key role in determining vulnerability to cocaine addiction and may offer an entirely new direction for the development of anti-addiction therapies. In animal studies, the scientists found that a molecule called microRNA-212 was increased in the brains of test animals that had extended access to cocaine.

8 Jul 2010

York University study shows misoprostol prevents cell communication

A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function.

8 Jul 2010

Women aged 27-45 have heightened sex drive in response to dwindling fertility: Study

As more women wait until their 30s and 40s to have children, they are more willing to engage in a variety of sexual activities to capitalize on their remaining childbearing years, according to new research by psychologists at The University of Texas at Austin.

8 Jul 2010

Regular use of fish oil supplements reduces risk of invasive ductal breast cancer

A recent report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, adds to the growing evidence that fish oil supplements may play a role in preventing chronic disease.

8 Jul 2010

Scientist leads global discussion, research on insula

A scientist at Barrow Neurological Institute is leading the global discussion and research on a hidden lobe of the brain called the insula. A.D. "Bud" Craig, PhD, who began studying the often-ignored lobe more than two decades ago, has organized and edited a special edition of the journal Brain Structure and Function dedicated to the emerging medical and scientific interest in the insula.

8 Jul 2010

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice - still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.

8 Jul 2010

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

Children with asthma are at increased risk of developing pneumonia as a complication of influenza, reports a study in the July issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

8 Jul 2010

Vitamin E may help prevent cognitive deterioration in elderly people: Study

High levels of several vitamin E components in the blood are associated with a decreased risk for Alzheimer's disease in advanced age, suggesting that vitamin E may help prevent cognitive deterioration in elderly people. This is the conclusion reached in a Swedish study published in the July 2010 issue of the Journal of Alzheimer's Disease.

8 Jul 2010

Scientists identify new strategy for treating movement disorders

Scientists at the Gladstone Institute of Neurological Disease and Stanford University have shown how key circuits in the brain control movement. The research, published in the journal Nature not only establishes the function of these circuits, but offers promise for treating movement related disorders, such as Parkinson's disease.

8 Jul 2010

Common glucose test accurately predicts Type II adult-onset diabetes, study finds

A common test to diagnose gestational diabetes -- a temporary condition which can harm both mother and child if left untreated -- also has predictive power for Type II adult-onset diabetes, a new Tel Aviv University study finds.

8 Jul 2010

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.

7 Jul 2010

Medical Research News

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Study demonstrates causal relationship between onset of Creutzfeldt-Jakob disease and general surgery

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Study: 30-minute massage improves psychological, physiological state of patients with tension headache

Alzheimer's disease patients may have decreased ability to experience emotions

Dietary protein intake may reduce bone density in overweight, postmenopausal women: Research

Study of latest in clinical data technology applied to Phase II clinical trial in South Africa

Patients with hyperglycaemia during acute illness have increased risk of developing diabetes: Researchers

UTHealth Biotechnology Commercialization Center leases over three-quarters of available space

MicroRNA-212 plays key role in determining vulnerability to cocaine addiction: Study

York University study shows misoprostol prevents cell communication

Women aged 27-45 have heightened sex drive in response to dwindling fertility: Study

Regular use of fish oil supplements reduces risk of invasive ductal breast cancer

Scientist leads global discussion, research on insula

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

Vitamin E may help prevent cognitive deterioration in elderly people: Study

Scientists identify new strategy for treating movement disorders

Common glucose test accurately predicts Type II adult-onset diabetes, study finds

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News